PAIA
GILD icon

Park Avenue Institutional Advisers’s Gilead Sciences GILD Stock Holding History

Park Avenue Institutional Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,619
Closed -$719K – 169
2016
Q2 		$719K Sell
8,619
-460
-5% -$40.8K 0.62% 38
2016
Q1 		$834K Sell
9,079
-255
-3% -$23K 0.72% 30
2015
Q4 		$945K Sell
9,334
-428
-4% -$44.5K 0.81% 26
2015
Q3 		$959K Sell
9,762
-282
-3% -$31.3K 0.85% 23
2015
Q2 		$1.18M Buy
+10,044
New +$1.1M 0.95% 18

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Park Avenue Institutional Advisers's GILD Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 8,619 shares — an estimated $719K sold.

Park Avenue Institutional Advisers first reported a position in GILD in Q2 2015 and held it in 5 quarters. The position peaked at $1.18M in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 8,619 Gilead Sciences shares in Q3 2016, an estimated $719K.
  • Park Avenue Institutional Advisers first reported a position in Gilead Sciences in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Gilead Sciences position peaked at $1.18M in Q2 2015.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.